Executive Board

The Executive Board is responsible for managing the company. Its members are jointly accountable for the management of the company. The Executive Board has, as its prime responsibility, the group's strategic management, resource allocation, financial accounting and reporting, risk management, and corporate control.

Dr. Andreas Eckert
Chairman of the Executive Board
Dr. Andreas Eckert completed his academic studies in Heidelberg, New York and Berlin. After graduating with a Dr. phil. degree in Heidelberg, he worked for the Secretary-General of the United Nations as an Information Officer in New York, Latin America, Asia and Africa. Dr. Eckert returned to Berlin after the German reunification as an independent management consultant. He then founded the Eckert & Ziegler Strahlen- und Medizintechnik AG as well as other technology organisations predominantly involved in the life science branches.

Dr. Harald Hasselmann
Member of the Executive Board
Business Segment Radiation Therapy

After completing his doctorate studies in economics he gained experience at various international pharmaceutical companies. He was head of controlling for Europe at Bayer Pharma, managing director at Schering’s Hungarian subsidiary and director of the Berlin-based biotech company metaGen. He has held various positions in large and medium-sized healthcare companies and has an excellent track record in sales, controlling and implementing restructuring measures. With effect from October 1, 2015, Dr. Harald Hasselmann became Managing Director for Sales and Finances at Eckert & Ziegler BEBIG. In January 2017 he was recruited as a member of the Executive Board of Eckert & Ziegler.

Dr. Lutz Helmke

Dr. Lutz Helmke
Member of the Executive Board
Business Segment Radiopharma
After graduating from Radio Chemistry studies and receiving his PhD, he switched into the medical device industry and started his career in the marketing department of Biotronik. After that, he held over a period of 25 years various management positions at Abbott, St. Jude Medical, and most recently MagForce. As head of various task forces within the German Medical Technology Association BVMed, Dr. Helmke also gained a wide range of experience in market launches and reimbursement aspects of medical devices. In September 2018 Dr. Helmke was appointed to the Executive Board of Eckert & Ziegler.